PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Intestinal Research10.5217/ir.2018.000232018164588-598High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in IndiaAshish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahujahttp://irjournal.org/upload/pdf/ir-2018-00023.pdf, http://irjournal.org/journal/view.php?doi=10.5217/ir.2018.00023, http://www.irjournal.org/upload/pdf/ir-2018-00023.pdf
Gastroenterology10.1016/s0016-5085(18)31541-520181546S-367Sa1717 - Very High Rate of Tuberculosis Complicating Infliximab Therapy for Inflammatory Bowel Disease Despite Tuberculosis Screening in IndiaAshish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P. Yadav, Sandeep Goyal, Pratap Mouli Venigalla, Govind K. Makharia, Vineet Ahujahttps://api.elsevier.com/content/article/PII:S0016508518315415?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508518315415?httpAccept=text/plain
Australasian Journal of Dermatology10.1111/ajd.120532013552140-141Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screeningAlexander Gin, Con Dolianitishttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajd.12053, http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajd.12053/fullpdf
Gastroenterology10.1016/s0016-5085(19)38491-420191566S-636Su1854 – Profile of Patients with Inflammatory Bowel Disease Who Developed Active Tuberculosis Despite Negative Screening Prior to the Introduction of Anti-TNF TherapyLuciana Barros, Cláudia Braga, Tárcia N. Gomes, Orlando Ambroginihttps://api.elsevier.com/content/article/PII:S0016508519384914?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508519384914?httpAccept=text/plain
Inflammatory Bowel Diseases10.1093/ibd/zaa010.132202026Supplement_1S52-S53P016 IMPROVING TUBERCULOSIS RE SCREENING IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY: A SINGLE CENTER QUALITY IMPROVEMENT INITIATIVE.David Drevno, Sherry Hickok, Sabina Alihttp://academic.oup.com/ibdjournal/article-pdf/26/Supplement_1/S52/31943981/zaa010.132.pdf, http://academic.oup.com/ibdjournal/article-pdf/26/Supplement_1/S52/31943981/zaa010.132.pdf
Gastroenterology10.1016/s0016-5085(19)38170-320191566S-516-S-517Su1150 – Risk of Tuberculosis in Patients with Inflammatory Bowel Disease on Infliximab Or Adalimumab is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-AnalysisSaurabh Kedia, Pratap Mouli Venigalla, Nagesh Kamat, Jeeva Sankar, Vineet Ahujahttps://api.elsevier.com/content/article/PII:S0016508519381703?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508519381703?httpAccept=text/plain
Gastroenterology10.1053/j.gastro.2019.11.21320201583S84P016 IMPROVING TUBERCULOSIS RE SCREENING IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY: A SINGLE CENTER QUALITY IMPROVEMENT INITIATIVE.David Drevno, Sherry Hickok, Sabina Alihttps://api.elsevier.com/content/article/PII:S0016508519418015?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508519418015?httpAccept=text/plain
Inflammatory Bowel Diseases10.1093/ibd/izy08820182461266-1271Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel DiseaseEirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Ioannis E Koutroubakishttp://academic.oup.com/ibdjournal/article-pdf/24/6/1266/24831429/izy088.pdf
Inflammatory Bowel Diseases10.1093/ibd/izy08920182461272-1273Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel DiseaseKonstantinos H Katsanos, Kallirroi Kyriakidi, Alexandros Skamnelos, Dimitrios K Christodoulouhttp://academic.oup.com/ibdjournal/article-pdf/24/6/1272/24831434/izy089.pdf
Intestinal Research10.5217/ir.2016.14.2.1832016142183Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitisJatinderpal Singh, Amarender S Puri, Sanjeev Sachdeva, Puja Sakhuja, Kulandaivelu Arivarasanhttp://www.irjournal.org/upload/pdf/ir-14-183.pdf